BSE filing, NSE: PHCAP. Summary written from the filing by ALFA Finder's alert engine.
P H Capital Ltd: key numbers
- Share price
- ₹125.00
- Market cap
- ₹412.5 Cr
- Revenue (annual)
- ₹112.7 Cr
- Net profit (annual)
- ₹3.24 Cr
- P/E (TTM)
- -101.7×Sector 19.7×
- Promoter holding
- 72.70%+0.00% QoQ
- FII holding
- 2.42%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from P H Capital Ltd
All →P H Capital Merger & Restructuring Worth ₹0.15 Cr
P H Capital to incorporate wholly-owned subsidiary StrategicAlpha Research Platforms for research analyst services. Cash consideration up to ₹0.15 Crore, with SEBI registration pending.
- Value
- ₹0.15 Cr
P H Capital Merger & Restructuring Worth ₹7 Cr
P H Capital is incorporating wholly-owned subsidiary Strategic Alpha Asset Management for portfolio management. Up to ₹7 Crore in cash marks its entry into asset management.
- Value
- ₹7.00 Cr
P H Capital Merger & Restructuring Worth ₹0.01 Cr
P H Capital Limited is incorporating AHB Advisors Private Limited, a wholly owned subsidiary for corporate advisory. Cash consideration is up to ₹0.01 Crore.
- Value
- ₹0.01 Cr
P H Capital Bonus Issue
P H Capital Board recommended a 10:1 bonus from free reserves. Record date is 07 October 2026 with shares to be credited by 08 October 2026.
P H Capital Management Change
P H Capital appointed Ms. Shrusti Barlota as Company Secretary and Compliance Officer effective October 8, 2026. She is an ICSI associate with corporate compliance experience.
P H Capital Bonus Issue
PH Capital approved allotment of 30.01 Crore bonus shares at 10:1. Board also approved incorporation of three wholly-owned subsidiaries for advisory, research, and portfolio management.
- Value
- ₹30.00 Cr
Other bonus issue announcements
All →Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels' board recommended a 1:1 bonus issue from free reserves on 23 October 2026. Paid-up capital rises from Rs.25.00 Crore to Rs.50.00 Crore, subject to AGM/postal ballot on 25 November 2026.